| Title |
Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia - Volume 23, Number 1—January 2017 - Emerging Infectious Diseases journal - CDC
|
|---|---|
| Published in |
Emerging Infectious Diseases, January 2017
|
| DOI | 10.3201/eid2301.161497 |
| Pubmed ID | |
| Authors |
Soraya E. Morales-López, Claudia M. Parra-Giraldo, Andrés Ceballos-Garzón, Heidys P. Martínez, Gerson J. Rodríguez, Carlos A. Álvarez-Moreno, José Y. Rodríguez |
| Abstract |
Candida auris is an emerging multidrug-resistant fungus that causes a wide range of symptoms. We report finding 17 cases of C. auris infection that were originally misclassified but correctly identified 27.5 days later on average. Patients with a delayed diagnosis of C. auris had a 30-day mortality rate of 35.2%. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 18% |
| United Kingdom | 2 | 18% |
| Netherlands | 2 | 18% |
| Unknown | 5 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 73% |
| Scientists | 3 | 27% |
Mendeley readers
The data shown below were compiled from readership statistics for 217 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Unknown | 216 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 39 | 18% |
| Researcher | 27 | 12% |
| Student > Ph. D. Student | 21 | 10% |
| Student > Master | 18 | 8% |
| Other | 14 | 6% |
| Other | 36 | 17% |
| Unknown | 62 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 18% |
| Biochemistry, Genetics and Molecular Biology | 30 | 14% |
| Immunology and Microbiology | 28 | 13% |
| Agricultural and Biological Sciences | 20 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 23 | 11% |
| Unknown | 72 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 55. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2022.
All research outputs
#762,733
of 25,161,628 outputs
Outputs from Emerging Infectious Diseases
#912
of 9,683 outputs
Outputs of similar age
#16,355
of 432,640 outputs
Outputs of similar age from Emerging Infectious Diseases
#9
of 132 outputs
Altmetric has tracked 25,161,628 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,683 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 45.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,640 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 132 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.